FDA Accepts the Pharmacosmos Facility

December 2, 2005

Pharmacosmos has received the official accept from the US Food & Drug Administration (FDA) for the manufacturing of Dextran and Iron Dextran compounds.

About Pharmacosmos A/S

Pharmacosmos A/S is a Danish pharmaceutical company that manufactures and markets injectable iron pharmaceuticals for iron repletion in humans and Dextran used in various clinical and technical compounds including solutions for infusion.

Pharmacosmos is one of the leading companies within its area of business and markets its products in more than 50 countries worldwide. The manufacturing is controlled and approved the Danish Medicines Agency and the US Food & Drug Administration.

Back to Recent News